Next-Generation Oral Dissolvable Film for Vitamin D3 Delivery

Publication ID: 24-11857557_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Oral Dissolvable Film for Vitamin D3 Delivery,” Published Technical Disclosure No. 24-11857557_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857557_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,557.

Summary of the Inventive Concept

A futuristic oral dissolvable film technology that revolutionizes vitamin D3 delivery by incorporating protective coatings, stabilizing agents, and bioavailability enhancers to ensure optimal absorption and convenience.

Background and Problem Solved

The original patent's oral dissolvable film technology has limitations in terms of stability, bioavailability, and user convenience. The new inventive concept addresses these limitations by introducing advanced features that prevent degradation, enhance absorption, and provide personalized dosing.

Detailed Description of the Inventive Concept

The next-generation oral dissolvable film technology comprises a moisture-sensitive active ingredient coated with a protective layer, ensuring stability during storage and shipment. The film is manufactured using a novel process incorporating a stabilizing agent to prevent degradation. Additionally, the film can be integrated into a wearable patch for extended release or formulated with a bioavailability enhancer for improved absorption. Furthermore, 3D printing technology enables personalized dosing tailored to individual vitamin D3 needs.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in oral dissolvable film technology by incorporating protective coatings, stabilizing agents, and bioavailability enhancers, which are not present in the original patent. These advancements provide a significant improvement in stability, bioavailability, and user convenience, making the original inventive concept obsolete.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include using different types of protective coatings, stabilizing agents, or bioavailability enhancers. Additionally, the film could be designed for sublingual or buccal administration, or integrated into other wearable devices or medical implants.

Potential Commercial Applications and Market

The next-generation oral dissolvable film technology has vast commercial potential in the vitamin D3 supplement market, particularly in the areas of personalized medicine, wearable technology, and medical devices. The technology could also be applied to other active ingredients, expanding its market reach.

Field of Art

Pharmaceutical formulation and drug delivery systems, specifically oral dissolvable film (ODF) technologies for delivering active pharmaceutical ingredients like vitamin D3

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical formulation scientist or chemical engineer with expertise in drug delivery systems, polymer chemistry, and film manufacturing techniques, holding at least a master's degree with 3-5 years of experience in developing oral drug delivery technologies

Obviousness Rationale

A person having ordinary skill in the art would recognize that the published technical disclosure represents predictable variations and extensions of the source patent's oral dissolvable film technology. The proposed modifications such as protective coatings, stabilizing agents, and bioavailability enhancers are well-known techniques in pharmaceutical formulation that would be obvious to implement for improving drug delivery performance. The core ODF technology remains fundamentally unchanged, with the variations representing incremental improvements that a skilled practitioner would readily conceive.

Obvious Combinations & Variations

Source Patent Element
Oral dissolvable film containing vitamin D3 with specific composition of water, sodium carboxymethyl cellulose, and polyvinylpyrrolidone
PTD Variation
Adding a protective moisture-resistant coating to prevent active ingredient degradation
Obviousness Reasoning
Protective coatings for moisture-sensitive pharmaceuticals are a known technique in the art, representing a predictable solution to stability challenges with minimal inventive effort
Source Patent Element
Method of delivering vitamin D3 via oral dissolvable film
PTD Variation
Incorporating bioavailability enhancers to improve absorption
Obviousness Reasoning
Enhancing drug absorption through excipient selection is a standard pharmaceutical formulation approach that would be obvious to a skilled formulation scientist
Source Patent Element
Oral administration of vitamin D3 film
PTD Variation
3D printing technology for personalized dosage customization
Obviousness Reasoning
Personalized medicine and advanced manufacturing techniques are emerging trends that a PHOSITA would recognize as an obvious extension of existing drug delivery technologies
Source Patent Element
Basic oral dissolvable film composition
PTD Variation
Wearable patch design for extended release
Obviousness Reasoning
Transdermal and extended-release drug delivery are well-established pharmaceutical engineering techniques that represent a predictable modification of existing ODF technologies
Source Patent Element
Vitamin D3 delivery via oral film
PTD Variation
Alternative administration routes including sublingual and buccal delivery
Obviousness Reasoning
Exploring multiple administration routes is a standard practice in pharmaceutical development, representing an obvious variation that would be apparent to a skilled practitioner
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857557 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations in oral dissolvable film technology to be obvious and lacking in non-obvious inventive characteristics. The proposed modifications represent predictable extensions of known pharmaceutical formulation techniques, and therefore would not meet the non-obviousness requirements under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,557
TitleOral dissolvable film containing vitamin D3